158 related articles for article (PubMed ID: 15544522)
1. Vasoactive renal factors and the progression of diabetic nephropathy.
Wassef L; Langham RG; Kelly DJ
Curr Pharm Des; 2004; 10(27):3373-84. PubMed ID: 15544522
[TBL] [Abstract][Full Text] [Related]
2. The renin-angiotensin system and diabetic nephropathy.
Gurley SB; Coffman TM
Semin Nephrol; 2007 Mar; 27(2):144-52. PubMed ID: 17418683
[TBL] [Abstract][Full Text] [Related]
3. Role of angiotensin II in diabetic nephropathy.
Kennefick TM; Anderson S
Semin Nephrol; 1997 Sep; 17(5):441-7. PubMed ID: 9316212
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of RAS in diabetic nephropathy.
Yacoub R; Campbell KN
Int J Nephrol Renovasc Dis; 2015; 8():29-40. PubMed ID: 25926752
[TBL] [Abstract][Full Text] [Related]
5. Preventing end-stage renal disease in diabetic patients - dual blockade of the renin-angiotensin system (Part II).
Jacobsen PK
J Renin Angiotensin Aldosterone Syst; 2005 Sep; 6(2):55-68. PubMed ID: 16470484
[TBL] [Abstract][Full Text] [Related]
6. The reno-protective effect of the dual blockade of the renin angiotensin system (RAS).
Luno J; Praga M; de Vinuesa SG
Curr Pharm Des; 2005; 11(10):1291-300. PubMed ID: 15853685
[TBL] [Abstract][Full Text] [Related]
7. The intrarenal renin-angiotensin system and diabetic nephropathy.
Carey RM; Siragy HM
Trends Endocrinol Metab; 2003 Aug; 14(6):274-81. PubMed ID: 12890592
[TBL] [Abstract][Full Text] [Related]
8. Physiologic actions and molecular expression of the renin-angiotensin system in the diabetic rat.
Anderson S
Miner Electrolyte Metab; 1998; 24(6):406-11. PubMed ID: 9930380
[TBL] [Abstract][Full Text] [Related]
9. Dual blockade of the renin-angiotensin system in diabetic nephropathy.
Wade VL; Gleason BL
Ann Pharmacother; 2004; 38(7-8):1278-82. PubMed ID: 15187210
[TBL] [Abstract][Full Text] [Related]
10. Vitamin D and diabetic nephropathy.
Li YC
Curr Diab Rep; 2008 Dec; 8(6):464-9. PubMed ID: 18990303
[TBL] [Abstract][Full Text] [Related]
11. Diabetic nephropathy: where hemodynamics meets metabolism.
Forbes JM; Fukami K; Cooper ME
Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):69-84. PubMed ID: 17318765
[TBL] [Abstract][Full Text] [Related]
12. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
Song JH; Lee SW; Suh JH; Kim ES; Hong SB; Kim KA; Kim MJ
Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
[TBL] [Abstract][Full Text] [Related]
13. The role of angiotensin II in diabetic nephropathy: emphasis on nonhemodynamic mechanisms.
Wolf G; Ziyadeh FN
Am J Kidney Dis; 1997 Jan; 29(1):153-63. PubMed ID: 9002545
[TBL] [Abstract][Full Text] [Related]
14. Renal functional responses in diabetic nephropathy following chronic bilateral renal denervation.
Yao Y; Davis G; Harrison JC; Walker RJ; Sammut IA
Auton Neurosci; 2017 May; 204():98-104. PubMed ID: 27727024
[TBL] [Abstract][Full Text] [Related]
15. Renal iron accelerates the progression of diabetic nephropathy in the HFE gene knockout mouse model of iron overload.
Chaudhary K; Chilakala A; Ananth S; Mandala A; Veeranan-Karmegam R; Powell FL; Ganapathy V; Gnana-Prakasam JP
Am J Physiol Renal Physiol; 2019 Aug; 317(2):F512-F517. PubMed ID: 31188032
[TBL] [Abstract][Full Text] [Related]
16. Trientine and renin-angiotensin system blockade ameliorate progression of glomerular morphology in hypertensive experimental diabetic nephropathy.
Moya-Olano L; Milne HM; Robinson JM; Hill JV; Frampton CM; Abbott HF; Turner R; Kettle AJ; Endre ZH
Pathol Int; 2011 Nov; 61(11):652-61. PubMed ID: 22029676
[TBL] [Abstract][Full Text] [Related]
17. Na+,K+-ATPase is modulated by angiotensin II in diabetic rat kidney--another reason for diabetic nephropathy?
Fekete A; Rosta K; Wagner L; Prokai A; Degrell P; Ruzicska E; Vegh E; Toth M; Ronai K; Rusai K; Somogyi A; Tulassay T; Szabo AJ; Ver A
J Physiol; 2008 Nov; 586(22):5337-48. PubMed ID: 18818245
[TBL] [Abstract][Full Text] [Related]
18. Beneficial impact on cardiovascular risk factors by dual blockade of the renin-angiotensin system in diabetic nephropathy.
Jacobsen P; Parving HH
Kidney Int Suppl; 2004 Nov; (92):S108-10. PubMed ID: 15485400
[TBL] [Abstract][Full Text] [Related]
19. Vasoactive hormones and the diabetic kidney.
Maric C
ScientificWorldJournal; 2008 Apr; 8():470-85. PubMed ID: 18454258
[TBL] [Abstract][Full Text] [Related]
20. The renin-angiotensin system and the long-term complications of diabetes: pathophysiological and therapeutic considerations.
Gilbert RE; Krum H; Wilkinson-Berka J; Kelly DJ
Diabet Med; 2003 Aug; 20(8):607-21. PubMed ID: 12873287
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
